{{medical}}[[File:Cancer_requires_multiple_mutations_from_NIH.png|thumb]]
'''惡性轉化'''（Malignant transformation）是指細胞或[[組織_(生物學)|組織]]產生一系列[[遺傳學|遺傳學]]上的變化，並獲得惡性增殖（無限增殖）和轉移能力的過程。惡性轉化在體內可能發生於正常細胞或組織中， 也可能發生於[[良性腫瘤|良性腫瘤]]中。發生惡性轉化的細胞或組織最終可能會發展為[[惡性腫瘤|惡性腫瘤]]<ref>{{cite web|url=https://training.seer.cancer.gov/brain/tumors/abstract-code-stage/transformation.html|title=MALIGNANT TRANSFORMATION}}</ref><ref name=Man2010>{{cite journal|author1=Tsz-Kwong Man|author2=etal|title=Chapter 15 – Genomic and Proteomic Profiling of Osteosarcoma|journal=Bone Cancer: Progression and Therapeutic Approaches|year=2010|pages=181–192}}</ref>。另外，研究人員為了方便研究，也可能在體外使用特殊技術方法對細胞進行惡性轉化<ref name=MITCHELL1997/>。

==成因==
不健康的生活習慣，比如[[吸菸|吸菸]]、不健康的飲食、[[酗酒|酗酒]]、混亂的[[性生活|性生活]]等可能造成體內的惡性轉化，產生惡性腫瘤。此外，病毒、細菌的感染也可能造成體內細胞或組織的惡性轉化<ref name=Doll>{{cite journal |vauthors=Doll R, Peto R |title=The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today |journal=J. Natl. Cancer Inst. |volume=66 |issue=6 |pages=1191–308 |year=1981 |pmid=7017215 |doi= 10.1093/jnci/66.6.1192|url=}}</ref><ref name=Blot>{{cite journal |vauthors=Blot WJ, Tarone RE |title=Doll and Peto's quantitative estimates of cancer risks: holding generally true for 35 years |journal=J. Natl. Cancer Inst. |volume=107 |issue=4 |page= djv044|year=2015 |pmid=25739419 |doi=10.1093/jnci/djv044 |url=}}</ref><ref name="pmid26271254">{{cite journal |vauthors=Song M, Giovannucci EL |title=RE: Doll and Peto's Quantitative Estimates of Cancer Risks: Holding Generally True for 35 Years |journal=J. Natl. Cancer Inst. |volume=107 |issue=10 |page= djv240|year=2015 |pmid=26271254 |doi=10.1093/jnci/djv240 |url=}}</ref><ref name="pmid7762738">{{cite journal |vauthors=Correa P |title=Helicobacter pylori and gastric carcinogenesis |journal=Am. J. Surg. Pathol. |volume=19 Suppl 1 |issue= |pages=S37–43 |year=1995 |pmid=7762738 |doi= |url=}}</ref>。一定水平的[[重金屬|重金屬]]，如[[鎳|鎳]]、[[鎘|鎘]]也可造成惡性轉化<ref name="pmid26109463">{{cite journal |vauthors=Nawrot TS, Martens DS, Hara A, Plusquin M, Vangronsveld J, Roels HA, Staessen JA |title=Association of total cancer and lung cancer with environmental exposure to cadmium: the meta-analytical evidence |journal=Cancer Causes Control |volume=26 |issue=9 |pages=1281–8 |year=2015 |pmid=26109463 |doi=10.1007/s10552-015-0621-5 |url=}}</ref><ref name="pmid24040994">{{cite journal |vauthors=Cohen SM, Arnold LL, Beck BD, Lewis AS, Eldan M |title=Evaluation of the carcinogenicity of inorganic arsenic |journal=Crit. Rev. Toxicol. |volume=43 |issue=9 |pages=711–52 |year=2013 |pmid=24040994 |doi=10.3109/10408444.2013.827152 |url=}}</ref><ref name="pmid23314041">{{cite journal |vauthors=Bhattacharjee P, Banerjee M, Giri AK |title=Role of genomic instability in arsenic-induced carcinogenicity. A review |journal=Environ Int |volume=53 |issue= |pages=29–40 |year=2013 |pmid=23314041 |doi=10.1016/j.envint.2012.12.004 |url=}}</ref><ref name="pmid23125218">{{cite journal |vauthors=Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi D, Duan X, Xuan A, Zhang W, Lu J, Zhuang Z, Zeng G |title=MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism |journal=Carcinogenesis |volume=34 |issue=2 |pages=446–53 |year=2013 |pmid=23125218 |doi=10.1093/carcin/bgs343 |url=}}</ref>。

==機制==
惡性轉化過程中，細胞會發生一系列遺傳學上的變化<ref name=Man2010/>。

基因突變是惡性轉化的成因之一，[[抑癌基因|抑癌基因]]和（或）[[原癌基因|原癌基因]]的突變會造成惡性轉化。根據統計，[[乳腺癌|乳腺癌]]組織中平均基因突變數達20,000處以上<ref name="pmid22492626">{{cite journal | author = Yost SE | author2 = Smith EN | author3 = Schwab RB | author4 = Bao L | author5 = Jung H| author6 = Wang X | author7 = Voest E | author8 = Pierce JP | author9 = Messer K| author10 = Parker BA | author11 = Harismendy O| author12 = Frazer KA | title = Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens | journal = Nucleic Acids Res. | volume = 40 | issue = 14 | pages = e107 |date=August 2012 | pmid = 22492626 | pmc = 3413110 | doi = 10.1093/nar/gks299 }}</ref>，普通的惡性黑色素瘤組織中平均基因突變數則達到80,000處<ref name="pmid22622578">{{cite journal | author1 = Berger MF | author2 =ETAL|title = Melanoma genome sequencing reveals frequent PREX2 mutations | journal = Nature | volume = 485 | issue = 7399 | pages = 502–6 |date=May 2012 | pmid = 22622578 | pmc = 3367798 | doi = 10.1038/nature11071 }}</ref>。

此外，[[表觀遺傳學|表觀遺傳學]]上的改變也可能造成惡性轉化。比如，在惡性轉化過程中，部分與[[DNA修復|DNA修復]]相關的基因或其他基因可能會因[[啓動子|啓動子]]區域過[[DNA甲基化|甲基化]]而發生轉錄水平上的沉默<ref name=Illingworth>{{cite journal |vauthors=Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr AR, James KD, Turner DJ, Smith C, Harrison DJ, Andrews R, Bird AP |title=Orphan CpG islands identify numerous conserved promoters in the mammalian genome |journal=PLoS Genet. |volume=6 |issue=9 |pages=e1001134 |year=2010 |pmid=20885785 |pmc=2944787 |doi=10.1371/journal.pgen.1001134 |url=}}</ref><ref name="pmid27493446">{{cite journal |vauthors=Wei J, Li G, Dang S, Zhou Y, Zeng K, Liu M |title=Discovery and Validation of Hypermethylated Markers for Colorectal Cancer |journal=Dis. Markers |volume=2016 |issue= |pages=2192853 |year=2016 |pmid=27493446 |pmc=4963574 |doi=10.1155/2016/2192853 |url=}}</ref><ref name=Beggs>{{cite journal |vauthors=Beggs AD, Jones A, El-Bahrawy M, El-Bahwary M, Abulafi M, Hodgson SV, Tomlinson IP |title=Whole-genome methylation analysis of benign and malignant colorectal tumours |journal=J. Pathol. |volume=229 |issue=5 |pages=697–704 |year=2013 |pmid=23096130 |pmc=3619233 |doi=10.1002/path.4132 |url=}}</ref><ref name=Bernstein2015>Carol Bernstein and Harris Bernstein (2015). Epigenetic Reduction of DNA Repair in Progression to Cancer, Advances in DNA Repair, Prof. Clark Chen (Ed.), {{ISBN|978-953-51-2209-8}}, InTech,  Available from: http://www.intechopen.com/books/advances-in-dna-repair/epigenetic-reduction-of-dna-repair-in-progression-to-cancer</ref>。另外，在惡性轉化過程中，[[RNA干擾|RNA干擾]]等轉錄後調控機制也可能會發生改變。比如，乳腺癌組織中的多種miRNA會因為啓動子發生過甲基化而停止表達，後續的RNA干擾也因此而停止進行<ref>{{cite journal|last1=Vrba |first1=L |last2=Muñoz-Rodríguez |first2=JL |last3=Stampfer |first3=MR |last4=Futscher |first4=BW |year=2013 |title=miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer. |journal=PLOS ONE |volume=8 |number=1 |page=e54398 |doi=10.1371/journal.pone.0054398 |pmid=23342147 |pmc=3547033}}</ref>。

==體外惡性轉化==
[[File:HEK_293_cells_grown_in_tissue_culture_medium.jpg|thumb]]]]

{{See also2|{{link-en|永生化細胞系|Immortalised cell line}}}}

細胞生物學研究者為了方便研究，可能會在體外（''in vitro''）使用[[病毒|病毒]]感染等方法對動物細胞進行惡性轉化，獲得{{link-en|永生化細胞系|Immortalised cell line}}。比如[[HEK_293|HEK 293]]細胞就是使用5型[[腺病毒|腺病毒]]DNA片段惡性轉化的人[[胚胎|胚]][[腎|腎]]細胞。另外，在體外進行惡性轉化對研究體內（''in vivo''）的惡性轉化過程也有一定助益<ref>{{cite journal|author=Paul H. Black|title=Malignant Transformation in Vitro by Oncogenic Viruses|journal=JAMA. 1968;206(6):1258-1262.}}</ref><ref name=MITCHELL1997>{{cite journal|title=In Vitro Genotoxicity and Cell Transformation Assessment|author1=IAN DE G. MITCHELL|author2=ROBERT D. COMBES|journal=In Vitro Methods in Pharmaceutical Research|year=1997|pages=317–352}}</ref><ref name="pmid886304">{{cite journal |vauthors=Graham FL, Smiley J, Russell WC, Nairn R |title=Characteristics of a human cell line transformed by DNA from human adenovirus type 5 |journal=J. Gen. Virol. |volume=36 |issue=1 |pages=59–74 |date=July 1977 |pmid=886304 |doi=10.1099/0022-1317-36-1-59 |url=http://vir.sgmjournals.org/cgi/pmidlookup?view=long&pmid=886304 }}{{Dead link|date=2018年9月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>。

==參見==
*[[惡性腫瘤|惡性腫瘤]]
*{{link-en|永生化細胞系|Immortalised cell line}}

== 参考文献 ==
{{Reflist|30em}}

[[Category:细胞生物学|Category:细胞生物学]]
[[Category:肿瘤学|Category:肿瘤学]]